COST ESTIMATION AND RESOURCE UTILIZATION IN PATIENTS WITH BIPOLAR DISORDER FROM MAINTENANCE TO NEXT-RELAPSE EPISODE. A MEXICAN COHORT.

Author(s)

Doris Gutiérrez-Mora, MD, Ms1, Herman Soto-Molina, MES, Mr2, Armando González-Jaimes, MD, Mr3, Claudia Becerra-Palars, MC, MD11Instituto Nacional de Psiquiatría Ramón de la Fuente, México D.F, Mexico; 2 Universidad Autonoma del Estado de México, Toluca, Mexico; 3 Asociación Mexicana de Farmacovigilancia, México D.F, Mexico

OBJECTIVES: To assess resource utilization from a cohort of patients with acute bipolar mania (ABM) and perform a cost estimation from maintenance to next-relapse episode within a 52 week-follow up period in the Instituto Nacional de Psiquiatría Ramón De La Fuente (INP). METHODS: Data from ABM diagnosed patients between 2003 – 06 who received medical assistance at INP were prospectively collected according to the following inclusion criteria: 1) first manic episode treated at INP, and 2) received care from the Bipolar Disorder Clinic at INP. Only direct medical costs were considered (from the INP perspective) using a bottom up approach (drug treatment -DT-, laboratory tests and psychiatrist visits). Clinical data and resource utilization were obtained from individual medical records. Unitary costs were obtained from the Ministry of Health and adjusted to December 2006, expressed in Mexican pesos (MXN). The Inverse-Probability Weighting Method (IPW) was used for total mean cost estimation (TMC) and resource utilization, and a 1000-iteration bootstrap was used to obtain standard errors of TMC and resource utilization in the presence of censoring. Results are shown either as TMC (SD) or 95% CI. The recurrence probability for the first year was estimated using Kaplan-Meier survival curves. RESULTS: 51 ABM patients were included, 37% male, mean age 27.23 years (+10.15). An 11% data-censoring level was seen (including cost histories). The one-year recurrence rate was 40.44% (55.99% - 23.91%). 70.59% of patients took a one or two-drug treatment. The most common DT was valproate (74.51%). Average psychiatrist visits was 8.21 (+0.55). TMC of ABM patient was $13,795.26 (+1,365.05), $11,176.31- $16,630.01 95% IC. 72.21% of TMC corresponds to DT. CONCLUSION: Maintenance treatment's TMC is lower than relapse's in ABM patients, requiring, therefore, improved DT efficacy so to avoid the latter's costs.

Conference/Value in Health Info

2007-09, ISPOR Latin America 2007, Cartagena, Colombia

Value in Health, Vol. 10, No. 6 (November/December 2007)

Code

PMH6

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Mental Health

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×